FALLS CHURCH, Va., Aug. 8, 2019 /PRNewswire-PRWeb/ -- Clinical trial leaders in every biopharma company, large and small,
Come to Philadelphia Sept. 4 and 5 for the second Metrics Champion Consortium Summit. This will be an exclusive gathering of the top minds in trial performance metrics.
The summit begins with the first session Secrets to Implementing Successful Metric Programs, followed by the keynote session where Ken Getz — Associate Professor and Director, CSDD, Tufts University and Founder and Board Chair, CISCRP, clinical trials guru, founder of CenterWatch and an MCC partner — examines the patient engagement movement and its impact on clinical research execution.
The day continues with attendees picking the track that provides them with the information they need most: Vendor Oversight or Risk-Based Quality Management.
Vendor oversight is an all-new track developed to inform attendees on the impact of ICH E6(R2), developing healthy sponsor/vendor engagement and teams, clinical research organization (CRO) oversight and using metrics to manage vendor risk and performance.
Risk-based quality management focuses on emerging practices, the impact of ICH E6(R2) updates, risk management for small sponsors and developing and using a risk library. The breakout session topics provide opportunities to learn about:
Choose a track and come away with the skills needed to master metrics. Attendees will receive a complimentary summit summary report post conference.
Who Will Benefit: This event is designed for professionals from pharmaceutical, biotechnology and medical device companies; CROs; and other clinical service providers who have responsibilities in the following areas:
Conference Details: Clinical Trial Risk and Performance Management Summit **Presented by Metrics Champion Consortium** Sept. 4-5, 2019 – Philadelphia, PA http://www.fdanews.com/ctriskperformancemngmntsummit Tuition: Regular Pricing: $1,797 Significant team and MCC membership discounts are available.
Easy Ways to Register: Online: http://www.fdanews.com/ctriskperformancemngmntsummit By phone: 888-838-5578 or 703-538-7600
About MCC Leading the drug-development enterprise in the adoption and utilization of standardized metrics and benchmarks to drive performance improvement. Founded in 2006, MCC is the leading industry association dedicated to the development of standardized performance metrics to improve clinical trials. MCC provides the collaborative environment for biopharmaceutical and device sponsors, service providers and sites to improve clinical-trial development through use of MCC standardized performance metrics.
SOURCE Metrics Champion Consortium
Subscribe to our Free Newsletters!